References

  1. Mandrekar SJ & Sargent D. (2009). Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. Journal of Clinical Oncology 27: 4027-4034.
  2. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shaprio JD, Robitaille S, Price TJ, Shepard L, Au HJ, Langer C, Moore MJ & Zalcberg JR. (2008). K-ras mutations and benefit from cetuximab in advanced colorectal cancer. New England Journal of Medicine 359: 1757-1765.
  3. Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, Donea S, Ludwig H, Schuch G, Stroh C, Loos AH, Zubel A & Koralewski P. (2009). Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab ...

Get Modern Approaches to Clinical Trials Using SAS: Classical, Adaptive, and Bayesian Methods now with the O’Reilly learning platform.

O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.

Start your free trial